Mvix is effective in once daily dosing for erectile dysfunction/positive BPH results

Published: 2011-11-16 06:58:00

Updated: 2011-11-16 06:58:00

SK Chemicals announced that it has completed a 140 patient once-a-day dosing clinical study of mirodenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).

A total of 147 men suffering prostatic hyperplasia with moderate or severe lower urinary sym...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK